Search - tctmd.com

Displaying 261 - 280 of 288

Sort: Relevancy | Date

News Daily News

Un Test Podría Detectar qué Pacientes STEMI corren Riesgo de sufrir Nefropatía por Contraste tras someterse a una PCI

Jason Kahn

December 03, 2012

News Daily News

Test May Detect STEMI Patients at Risk for Contrast Nephropathy After PCI

Jason Kahn

December 03, 2012

News Conference News TCT 2012

DAPT Cessation Within 1 Year Increased Risk for Major Adverse Events

October 23, 2012

News Daily News

La Bivalirudina Reduce las Hemorragias en Pacientes NSTEMI sometidos a PCI

Jason Kahn

October 19, 2012

News Daily News

Bivalirudin Lowers Bleeding in NSTEMI Patients Undergoing PCI

Jason Kahn

October 19, 2012

News Industry News

OrbusNeich’s COMBO Dual Therapy Stent™ to be Featured in Multiple Clinical Data Presentations Next Week at TCT 2012(2)

October 16, 2012

News Industry News

OrbusNeich’s COMBO Dual Therapy Stent™ to be Featured in Multiple Clinical Data Presentations Next Week at TCT 2012

October 16, 2012

News Daily News

Reversible Anticoagulation Shows Promise for ACS Patients Undergoing Catheterization

August 14, 2012

News Daily News

La Anticoagulación Reversible parece Prometedora en Pacientes con SCA sometidos a Cateterización

August 14, 2012

News Industry News

OrbusNeich’s Combo Dual Therapy Stent™ Featured During Symposium at Angioplasty Summit TCTAP 2012

April 25, 2012

News Daily News

El Tratamiento Agresivo con Estatinas Reduce la Carga Lipídica de las Lesiones Obstructivas

April 05, 2012

News Daily News

Aggressive Statin Therapy Lowers Lipid Burden in Obstructive Lesions

April 05, 2012

News Daily News

Los Criterios del BARC Validados frente a las Definiciones Hemorrágicas Existentes

Leah Lawrence

March 23, 2012

News Daily News

BARC Criteria Validated Against Existing Bleeding Definitions

Leah Lawrence

March 23, 2012

News Daily News

Complications of In-Stent Restenosis High, Traditional Risk Factors Absent

Yael L. Maxwell

February 15, 2012

News Daily News

Induced Diuresis with Matched Hydration Reduces Contrast Nephropathy

January 17, 2012

News Conference News

EVOLVE: Bioabsorbable EES Noninferior to Permanent Polymer Version

November 10, 2011

News Conference News

PARIS: Early DAPT Nonadherence, A Small Problem with Big Consequences

November 09, 2011

News Industry News

Non-adherence to dual antiplatelet therapy following percutaneous coronary intervention results in higher rates of ischemic and bleeding events

November 08, 2011

News Industry News

Data from REMEDEE Trial Featuring OrbusNeich's ComboTM Dual Therapy Stent to Be Presented in Late Breaking Clinical Trials and First Report Investigations Session at TCT 2011

November 01, 2011

Advertisement

Un Test Podría Detectar qué Pacientes STEMI corren Riesgo de sufrir Nefropatía por Contraste tras someterse a una PCI

Test May Detect STEMI Patients at Risk for Contrast Nephropathy After PCI

DAPT Cessation Within 1 Year Increased Risk for Major Adverse Events

La Bivalirudina Reduce las Hemorragias en Pacientes NSTEMI sometidos a PCI

Bivalirudin Lowers Bleeding in NSTEMI Patients Undergoing PCI

OrbusNeich’s COMBO Dual Therapy Stent™ to be Featured in Multiple Clinical Data Presentations Next Week at TCT 2012(2)

OrbusNeich’s COMBO Dual Therapy Stent™ to be Featured in Multiple Clinical Data Presentations Next Week at TCT 2012

Reversible Anticoagulation Shows Promise for ACS Patients Undergoing Catheterization

La Anticoagulación Reversible parece Prometedora en Pacientes con SCA sometidos a Cateterización

OrbusNeich’s Combo Dual Therapy Stent™ Featured During Symposium at Angioplasty Summit TCTAP 2012

El Tratamiento Agresivo con Estatinas Reduce la Carga Lipídica de las Lesiones Obstructivas

Aggressive Statin Therapy Lowers Lipid Burden in Obstructive Lesions

Los Criterios del BARC Validados frente a las Definiciones Hemorrágicas Existentes

BARC Criteria Validated Against Existing Bleeding Definitions

Complications of In-Stent Restenosis High, Traditional Risk Factors Absent

Induced Diuresis with Matched Hydration Reduces Contrast Nephropathy

EVOLVE: Bioabsorbable EES Noninferior to Permanent Polymer Version

PARIS: Early DAPT Nonadherence, A Small Problem with Big Consequences

Non-adherence to dual antiplatelet therapy following percutaneous coronary intervention results in higher rates of ischemic and bleeding events

Data from REMEDEE Trial Featuring OrbusNeich's ComboTM Dual Therapy Stent to Be Presented in Late Breaking Clinical Trials and First Report Investigations Session at TCT 2011

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content